Valneva Receives Marketing Authorization in the UK for the World’s First Chikungunya Vaccine, IXCHIQ®
Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that the Medicines and Healthcare products Regulatory Agency (MHRA) has granted marketing authorization in ...
Valneva receives authorisation for world’s first Chikungunya vaccine
Valneva has received Medicines and Healthcare products Regulatory Agency (MHRA) authorisation in the UK for the world’s first - and only - Chikungunya vaccine, IXCHIQ. The single-dose vaccine is ...
Hoodline16h
University of Minnesota Advocate Highlights Persistent Need for Blood Donations During Winter Season
Blood donations drop in winter, but the need remains high; eligibility includes individuals over 16 or 17, with no deferral ...